Join
Live feed
·
INSIDERFilingvia Quantisnow
Ventyx Biosciences Inc. logo

CHIEF SCIENTIFIC OFFICER Nuss John converted options into 4,531 shares, increasing direct ownership by 0.98% to 469,113 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTYX· Ventyx Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTYX (Ventyx Biosciences Inc.) and more on Quantisnow.